Chadwick, D <br/><br/>
Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Dec 2012 
 - 2939-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dks333  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Retroviral Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active--methods<br/>Body Mass Index<br/>CD4 Lymphocyte Count<br/>Coinfection--drug therapy<br/>DNA, Viral--blood<br/>Drug Resistance, Viral<br/>Female<br/>Ghana<br/>HIV Infections--complications<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B, Chronic--complications<br/>Humans<br/>Male<br/>Middle Aged<br/>Transaminases--blood<br/>Treatment Outcome<br/>Viral Load